The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction

Cardiovascular Research

Volumn 61, Issue 3, 2004, Pages 559-569

  Tschöpe, Carsten ^a   Spillmann, Frank ^a   Altmann, Christine ^a   Koch, Matthias ^a   Westermann, Dirk ^a   Dhayat, Nasser ^a   Dhayat, Sameer ^a   Bascands, Jean Loup ^b   Gera, Lajos ^c   Hoffmann, Sigrid ^d   Schultheiss, Heinz Peter ^a   Walther, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSERM   (France)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hemodynamics; Infarction; Renin angiotensin system; Signal transduction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; IRBESARTAN; MESSENGER RNA; RIBONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ASSAY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; RECEPTOR DENSITY; RECEPTOR UPREGULATION; TRANSGENIC MOUSE; WILD TYPE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; GENE EXPRESSION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, BRADYKININ B1; RNA, MESSENGER; TETRAZOLES;

EID: 10744232874     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.10.018     Document Type: Article

References (39)

1. 9-bradykinin release following reperfusion of the ischemic rat heart. Br. J. Pharmacol. 115:1995;476-478.
2. Gainer J.V., Morrow J.D., Loveland A., King D.J., Brown N.J. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N. Engl. J. Med. 339:1998;1285-1292.
3. Tschöpe C., Schultheiss H.P., Walther T. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J. Cardiovasc. Pharmacol. 39:2002;478-487.
4. Stauss H.M., Zhu Y.C., Redlich T.et al. ACE inhibitors in infarct induced heart failure: bradykinin versus angiotensin II. J. Cardiovasc. Risk. 1:1994;255-262.
5. Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation. 95:1997;1115-1118.
6. Horiuchi M., Akishita M., Dzau V.J. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 33:1999;613-621.
7. Gohlke P., Pees C., Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by kinin-dependent mechanisms. Hypertension. 31:1998;349-355.
8. Tsutsumi Y., Matsubara H., Masaki H.et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J. Clin. Invest. 104:1999;925-935.
9. Yang X.-P., Liu Y-H., Mehta D.et al. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B2 kinin receptor gene knockout mice. Circ. Res. 88:2001;1072-1079.
10. Witherow F.N., Helmy A., Webb D.J., Fox K.A., Newby D.E. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation. 30(104):2001;2177-2181.
11. Tschöpe C., Heringer-Walther S., Koch M.et al. Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J. Hypertens. 18:2000;223-228.
12. Tschöpe C., Heringer-Walther S., Koch M.et al. Up-regulation of bradykinin B1-receptor expression after myocardial infarction. Br. J. Pharmacol. 129:2000;1537-1538.
13. Hoffmann S., Krause T., van Geel P.P.et al. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy. J. Mol. Med. 79:2001;601-608.
14. Larrivee J.F., Gera L., Houle S.et al. Non-competitive pharmacological antagonism at the rabbit B(1) receptor. Br. J. Pharmacol. 131:2000;885-892.
15. Tschöpe C., Reinecke A., Seidl U.et al. Functional, biochemical, and molecular-biological investigations of renal kallikrein-kinin system in diabetic rats. Am. J. Physiol. 277:1999;H2333-H2340.
16. Walther T., Schultheiss H.-P., Tschöpe C. Impaired angiotensin II regulation of renal C-type natriuretic peptide. Cardiovasc. Res. 51:2001;562-566.
17. Schanstra J.P., Bataille E., Marin Castano M.E.et al. The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J. Clin. Invest. 101:1998;2080-2091.
18. Noutsias M., Pauschinger M., Ostermann K.et al. Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med. Sci. Monit. 8:2002;59-71.
19. Tschöpe C., Walther-Heringer S., Walther T. The kinin B1 and B2 receptor after induction of myocardial infarction. A mini-review. Braz. J. Med. Biol. Res. 33:2000;701-708.
20. Faussner A., Bathon J.M., Proud D. Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation. Immunopharmacology. 45:1999;13-20.
21. Marceau F., Larrivee J.-F., Bouthillier J.et al. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit. Am. J. Physiol. 277:1999;R1568-R1578.
22. McLean P.G., Perretti M., Ahluwalia A. Kinin B1 receptors and cardiovascular system: regulation of expression and function. Cardiovasc. Res. 48:2000;194-210.
23. Kintsurashvili E., Duka I., Gavras I.et al. Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am. J. Physiol. 281:2001;H1778-H1783.
24. Ferreira A.J., Santos R.A., Almeida A.P. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 38:2001;665-668.
25. Kim W.S., Nakayama K., Nakagawa T.et al. Mouse submandibular gland prorenin-converting enzyme is a member of glandular kallikrein family. J. Biol. Chem. 266:1991;19283-19287.
26. Walther T., Siems W.-E., Hauke D.et al. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. FASEB J. 16:2002;1237-1341.
27. Erdös E.G., Marcic B.M. Kinins, receptors, kininases and inhibitors - where did they lead us? Biol. Chem. 382:2001;43-47.
28. Ignjatovic T., Tan F., Brovkovych V., Skidgel R.A., Erdos E.G. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J. Biol. Chem. 277:2002;16847-16852.
29. Silvestre J.S., Bergaya S., Tamarat R., Duriez M., Boulanger C.M., Levy B.I. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ. Res. 89:2001;678-683.
30. Liu Y.H., Yang X.P., Sharov V.G.et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99:1997;1926-1935.
31. Marin-Castano M.E., Schanstra J.P., Neau E.et al. Induction of functional bradykinin B(1)-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation. 105:2002;627-632.
32. Lagneux C., Bader M., Pesquero J.B., Demenge P., Ribuot C. Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice. Int. Immunopharmacol. 2:2002;815-822.
33. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 95:1995;46-54.
34. Zhu Y.Z., Zhu Y.C., Li J.et al. Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction. JRAAS. 1:2002;257-262.
35. Foucart S., Grondin L., Couture R., Nadeau R. Modulation of noradrenaline release by B1 and B2 kinin receptors during metabolic anoxia in the rat isolated atria. Can. J. Physiol. Pharmacol. 75:1997;639-645.
36. Chahine R., Adam A., Yamaguchi N., Gaspo R., Regoli D., Nadeau R. Protective effects of bradykinin on the ischemic heart: implication of the B1 receptor. Br. J. Pharmacol. 108:1993;318-322.
37. Bouchard J.F., Chouinard J., Lamontagne D. Role of kinins in the endothelial protective effect of ischemic preconditioning. Br. J. Pharmacol. 123:1998;413-420.
38. Su J.B., Houel R., Heloire F.et al. Stimulation of bradykinin B(1) receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B(2) receptor stimulation. Circulation. 101:2000;1848-1853.
39. Kim N.N., Villegas S., Summerour S.R., Villarreal F.J. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J. Mol. Cell. Cardiol. 31:1999;457-466.